• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

      Smartphone Photos to Detect Anemia

      Smartphone Photos to Detect Anemia

      Ultrasound Catheter to Treat Hypertension

      Ultrasound Catheter to Treat Hypertension

    • Radiology
      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

      Ultrasound Catheter to Treat Hypertension

      Ultrasound Catheter to Treat Hypertension

      Antibacterial Smart Sutures Visible in CT Scans

      Antibacterial Smart Sutures Visible in CT Scans

      Terahertz Spectroscopy to Assess Severity of Skin Burns

      Terahertz Spectroscopy to Assess Severity of Skin Burns

    • Cardiology
      Scientists Grow Electrodes Inside The Body

      Scientists Grow Electrodes Inside The Body

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Tiny Patch for Cardiac Ultrasound Imaging

      Tiny Patch for Cardiac Ultrasound Imaging

      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

    • Surgery
      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Self-Assembling Peptides as a Bioink

      Self-Assembling Peptides as a Bioink

      3D Bioengineered Skin Grafts Fit Complex Anatomy

      3D Bioengineered Skin Grafts Fit Complex Anatomy

    • Nanomedicine
      Bottlebrush Particle for Synergistic Drug Combinations

      Bottlebrush Particle for Synergistic Drug Combinations

      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Empowering Stroke Survivors: Interview with Kirsten Carroll, General Manager at Kandu Health

      Empowering Stroke Survivors: Interview with Kirsten Carroll, General Manager at Kandu Health

      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Targeting BCL2 Proteins in Acute Myeloid Leukemia To Emerge As New Therapeutic Opportunity Says Kuick Research

November 17th, 2021 Kuick Research Releases

Global BCL-2 (B Cell Lymphoma 2) Inhibitors Market and Clinical Trials Insight 2025 Report Highlights:

  • Global BCL-2 Inhibitors Market Opportunity: >US$ 4 Billion by 2025
  • Insight on Market Indicators and Approved Drugs Sales Data
  • Global BCL-2 Inhibitors Market Absolute Growth: >300% ( 97% CAGR, 2018 – 2020)
  • Comprehensive Information On Ongoing Clinical Trials
  • Global BCL-2 inhibitors Clinical Trials By Company, Indication and Phase
  • Venetoclax Is The First Approved Drug Belonging To The Class Of BCL2 Inhibitor

 

Download Report

 

https://www.kuickresearch.com/report-global-bcl-2-b-cell-lymphoma-2-inhibitors-drug-therapeutics-market–size-sale-growth-clinical-trials-development-venetoclax

 

B-cell lymphoma 2 genes are crucial genes which are involved in regulating the balance between newly forming cells and old dying cells.  Bcl-2 was the first gene which has shown to promote prolonged cell survival rather than increased proliferation. However, any mutation in this gene results in formation of cancer and therefore they emerged as potential target to the researchers. Several cancers including breast, lymphoma, leukemia and lung cancer expresses a high amount of Bcl2. The therapeutic potential of this target has led to the development of Bcl-2 inhibitor which can be used in the management of cancer.

Venclexta/Vencylyxto is a first in class targeted drug designed to selectively bind and inhibit the B-cell lymphoma-2 (BCL-2) protein. The drug was developed by collaboration between Abbie and Roche. The drug is indicated as monotherapy as well as combinational therapy for the management of chronic lymphocytic leukemia, and acute lymphoblastic leukemia. In addition to CLL and AML, venetoclax has also been evaluated in other hematological malignancies including lymphomas and multiple myeloma. Apart from this, around 300 trials are ongoing which are evaluating the role of drug in combination with other cancer targeting regimens, which will drive the growth of market during forecast period.

The advent of Bcl-2 inhibitor in the management of cancer has greatly transformed the cancer therapeutics market. In a short span of time, Bcl2 inhibitory drugs have contributed to a significant share in the cancer therapeutics market owing to their high specificity and target ability towards cancer cell. Unlike conventional cancer therapies, the novel class of Bcl-2 inhibitors is not associated with any adverse side-effects and does not hamper the quality of life of patients, which further propel the growth of market.

The accelerated sales of the drug and the significant advantages have drawn the attention of several researchers and pharmaceutical companies to invest in this sector. The extensive efforts by the researchers and the rising collaboration among the pharmaceutical giants are expected to drive the future of the market in coming years. Till now, scientists have developed a cocktail of drugs has been developed which are mainly present in the early stages of the clinical trials and will take about 5-7 years to enter the market. The potential candidates in development include AZD4320, LP-108, Navitoclax, AT-101, and several others.

Although venetoclax has demonstrated impressive initial clinical activity in various hematological malignancies; intrinsic or acquired drug resistance represents a major obstacle for achieving effective and durable therapy with this agent. However, continuous research and development activities by researchers have led to identification of resistance mechanisms. Several preclinical studies utilizing combinational therapy has shown to overcome Venetoclax resistance. As per our report, the coming years will see dominace of combinational therapy owing to its high efficacy in targeting cancer.

The presence of large pharmaceutical sector and favourable governmental policies in US are expected to drive the dominance of the region for the next few years. In addition to this, the rising awareness among the individuals about the availability of the novel therapies and the increasing geriatric population will further fuel the growth of the market in this region. Apart from this, Europe is also emerging as a potential market due to subsequent rise in incidence of cancer. It is expected that in coming years, Bcl2 inhibitors will contribute to a major share in the overall cancer therapeutics market.

Contact:

Neeraj Chawla

Research Head

neeraj@kuickresearch.com

+91-9810410366

Sign up and submit a press release

Sponsored
Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH

New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH

C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

interviews & reviews
Empowering Stroke Survivors: Interview with Kirsten Carroll, General Manager at Kandu Health

Empowering Stroke Survivors: Interview with Kirsten Carroll, General Manager at Kandu Health

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email